gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with methotrexate in 1 studies
Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (methotrexate) | Trials (methotrexate) | Recent Studies (post-2010) (methotrexate) |
---|---|---|---|---|---|
638 | 31 | 243 | 41,593 | 5,666 | 11,969 |
Protein | Taxonomy | gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate (IC50) | methotrexate (IC50) |
---|---|---|---|
Thymidylate synthase | Escherichia coli | 1.8 | |
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 0.211 | |
Toll-like receptor 4 | Homo sapiens (human) | 1.04 | |
Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.08 | |
Dihydrofolate reductase | Homo sapiens (human) | 0.0522 | |
Dihydrofolate reductase | Mus musculus (house mouse) | 0.0331 | |
Dihydrofolate reductase | Bos taurus (cattle) | 0.0348 | |
Dihydrofolate reductase | Gallus gallus (chicken) | 0.0545 | |
Dihydrofolate reductase | Enterococcus faecium | 0.0014 | |
Dihydrofolate reductase | Lacticaseibacillus casei | 0.0138 | |
Thymidylate synthase | Homo sapiens (human) | 0.343 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0147 | |
Thymidylate synthase | Escherichia coli K-12 | 0.0181 | |
Dihydrofolate reductase | Escherichia coli K-12 | 0.1529 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.084 | |
Folate receptor beta | Homo sapiens (human) | 0.1585 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0011 | |
Cytochrome P450 11B1, mitochondrial | Bos taurus (cattle) | 0.0012 | |
Folate receptor alpha | Homo sapiens (human) | 0.2263 | |
Dihydrofolate reductase | Pneumocystis carinii | 0.0717 | |
Histidine decarboxylase | Rattus norvegicus (Norway rat) | 0.0014 | |
Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.01 | |
Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | 0.01 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Reduced folate transporter | Homo sapiens (human) | 0.012 | |
Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | 0.0174 | |
Folylpolyglutamate synthase, mitochondrial | Homo sapiens (human) | 3.2 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.0547 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | 0.11 | |
Dihydrofolate reductase | Bacillus anthracis | 0.0136 | |
Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0047 | |
Proton-coupled folate transporter | Homo sapiens (human) | 0.1207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and methotrexate
Article | Year |
---|---|
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |